Free tool

Stocks listed on Nasdaq GM

We cover 16 companies listed on Nasdaq GM. The median market value in the group is $687.92M. Across the group, the median move over the past trading day is +0.50%. Price change over the past year runs from −19.4% to +259.7% across the middle 80 percent of the group, with a median of +58.9%. Across the group, 1 company currently carries a tier A volume signal.

Other lists in this group

Table

16 of 701 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
APGEApogee Therapeutics, Inc.$10.21BLarge cap+257.11%
ETONEton Pharmaceuticals, Inc.$1.79BSmall cap+262.38%
KALVKalVista Pharmaceuticals Inc$1.44BSmall cap+98.68%
OMEROmeros Corporation$1.40BSmall cap+328.71%
CRONCronos Group Inc.$1.31BSmall cap+38.67%
JANXJanux Therapeutics, Inc.$1.15BSmall cap−19.10%
HELPCybin D/B/A Helus Pharma$995.81MSmall cap+77.71%
OABIOmniAb, Inc.$699.33MSmall cap+198.76%
AQSTAquestive Therapeutics, Inc.$676.51MSmall cap+40.00%
SGMTSagimet Biosciences Inc.$675.04MSmall cap+39.59%
ARCTArcturus Therapeutics Holdings Inc.$449.94MSmall cap−8.44%
TBRGTruBridge Inc$393.58MSmall cap+30.42%
YDESYD Bio Ltd$307.41MSmall cap−63.83%
BDSXBiodesix, Inc.$296.22MSmall cap+225.53%
XGNExagen Inc.$185.81MSmall cap−19.69%
ASRTAssertio Holdings Inc$151.86MSmall cap+103.46%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse